ESR2 and neoplasm: It is plausible that the predominance of ERα- or ERβ-associated signaling is related more to the ratio of expression of the two receptors than to their absolute expression; an increased expression of ERβ could favor the heterodimerization of ERα–Erβ, suppressing the pro-tumor signaling triggered by ERα [114].